Ginkgo Bioworks Holdings EPS - Earnings per Share 2020-2022 | DNA

Ginkgo Bioworks Holdings annual and quarterly earnings per share history from 2020 to 2022. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Ginkgo Bioworks Holdings EPS for the quarter ending March 31, 2022 was $-0.37, a 516.67% increase year-over-year.
  • Ginkgo Bioworks Holdings EPS for the twelve months ending March 31, 2022 was $-1.70, a 2025% increase year-over-year.
  • Ginkgo Bioworks Holdings 2021 annual EPS was $-1.39, a 1290% increase from 2020.
  • Ginkgo Bioworks Holdings 2020 annual EPS was $-0.1, a 0% decline from 2019.
  • Ginkgo Bioworks Holdings 2019 annual EPS was $-0.1, a INF% decline from .
Ginkgo Bioworks Holdings Annual EPS
2021 $-1.39
2020 $-0.10
2019 $-0.10
Ginkgo Bioworks Holdings Quarterly EPS
2022-03-31 $-0.37
2021-12-31 $1.23
2021-09-30 $-0.08
2021-06-30 $-2.48
2021-03-31 $-0.06
2020-12-31 $0.00
2020-09-30 $-0.02
2019-12-31 $0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.223B $0.314B
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $165.407B 10.06
Bio-Rad Laboratories (BIO.B) United States $14.121B 30.63
QIAGEN (QGEN) Netherlands $10.180B 16.07
Biohaven Pharmaceutical Holding (BHVN) United States $10.170B 0.00
Arcus Biosciences (RCUS) United States $1.792B 45.42
Emergent Biosolutions (EBS) United States $1.625B 6.95
Myovant Sciences (MYOV) United Kingdom $1.313B 0.00
Zymeworks (ZYME) Canada $0.365B 0.00
Gelesis Holdings (GLS) United States $0.122B 0.00
Ambrx Biopharma (AMAM) United States $0.110B 0.00
Enzo Biochem (ENZ) United States $0.103B 0.00
SQZ Biotechnologies (SQZ) United States $0.099B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00